Global Cell STR Testing Service Market Growth (Status and Outlook) 2025-2031

The global Cell STR Testing Service market size is predicted to grow from US$ 372 million in 2025 to US$ 564 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.

Cell STR (Short Tandem Repeat) testing service is a molecular biology technology based on STR locus analysis, mainly used for cell line identification, cross contamination detection, and cell genetic stability analysis. STR testing achieves unique identification of cell lines by analyzing specific short repeat sequences in cell DNA, ensuring the reliability of cell line sources used in experiments and biopharmaceutical research, and preventing misuse or contamination.

United States market for Cell STR Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cell STR Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cell STR Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cell STR Testing Service players cover ATCC, Eurofins Genomics, Promega Corporation, Multiplexio, Shanghai Beyotime, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cell STR Testing Service Industry Forecast” looks at past sales and reviews total world Cell STR Testing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell STR Testing Service sales for 2025 through 2031. With Cell STR Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell STR Testing Service industry.

This Insight Report provides a comprehensive analysis of the global Cell STR Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell STR Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell STR Testing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell STR Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell STR Testing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell STR Testing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Human Cell STR Test
Mouse Cell STR Test
Others

Segmentation by Application:
Pharmaceutical
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ATCC
Eurofins Genomics
Promega Corporation
Multiplexio
Shanghai Beyotime
Xiamen Immocell Biotechnology
Wuhan Boster Biological Technology
Beijing Microread Genetics
Beijing Abace Biology
Wuhan Pricella Biotechnology
Shanghai XP Biomed
Guangzhou IGE Biotechnology
Shanghai Zhong Qiao Xin Zhou Biotechnology
Shanghai Biowing Biotechnology Application
Tianjin KMD Bioscience
Wuhan Sunncell

Please note: The report will take approximately 2 business days to prepare and deliver.